Bio-Rad launches validated antibodies for rare cell and circulating tumor cell enumeration

Antibodies validated for use with Bio-Rad’s Celselect Slides™ enumeration stain kits to enable immunostaining of captured circulating tumor cells in liquid biopsy samples.

Adalimumab biosimilar by Biocon for Plaque Psoriasis (Psoriasis Vulgaris): Likelihood of Approval

Adalimumab biosimilar is under clinical development by Biocon and currently in Phase III for Plaque Psoriasis (Psoriasis Vulgaris).

March 19, 2024

Philips leader signed off on sale of respiratory devices despite evidence of health risks: report

Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Philips CEO Roy Jakobs approved

October 30, 2023

Esperion snags US label expansion for cardiovascular disease drugs – Pharmaceutical Technology

Share this article The FDA approved label expansions for Esperion Therapeutics Nexletol and Nexlizet. Credit: grandbrothers via Shutterstock. Esperion Therapeutics declared that the US Food

March 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.